Lifelight Health is developing innovative implantable medical devices for the targeted release of biologicals and small molecules without the need for injection. The system is based on a novel linker system that enables an actively controlled, precise and rapid release of approved drugs. This kind of localized therapy allows highly effective treatment of hard-to-reach targets, such as brain tumours, while minimizing side effects for patients.
|03/2023||Nomination at the Startup-Impuls startup competition in the category university startup|
|12/2022||Establishment of Lifelight Health GmbH|
|06/2022||Accepted for HTI BioIntelligence programme|
"The HTI program has been instrumental in our growth, providing essential financial resources, networking opportunities, and instructive workshops. The invaluable mentoring support has guided us through various startup challenges, making it an indispensable asset. Additionally, the program's nurturing environment has fostered a positive atmosphere for innovation and progress."
Simon Blazy, Lead Scientist of Lifelight Health